Kazia Therapeutics Limited (NASDAQ: KZIA)
$0.4090
+0.0030 ( +0.74% ) 147.3K
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.
Market Data
Open
$0.4090
Previous close
$0.4060
Volume
147.3K
Market cap
$13.40M
Day range
$0.4000 - $0.4140
52 week range
$0.1866 - $1.5800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 3 | Jul 10, 2024 |
| 6-k | Form 6-K | 1 | Jun 24, 2024 |
| 6-k | Form 6-K | 1 | May 23, 2024 |
| 6-k | Form 6-K | 3 | May 17, 2024 |
| 6-k | Form 6-K | 3 | May 01, 2024 |
| 6-k | Form 6-K | 3 | Apr 19, 2024 |
| 6-k | Form 6-K | 97 | Mar 27, 2024 |
| 6-k | Form 6-K | 3 | Mar 26, 2024 |
| 6-k | Form 6-K | 2 | Feb 21, 2024 |
| 6-k | Form 6-K | 4 | Jan 18, 2024 |